Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

BTOG 2020 | The impact of brain metastasis

Samreen Ahmed, FRCP, MD, University Hospitals of Leicester, UK, discusses the issue of brain metastasis and the lack of drugs that prevent this type of progression, highlighting osimertinib as a potential drug to reduce these negative outcomes. This interview took place at the 18th British Thoracic Oncology Group (BTOG) 2020 congress held in Dublin, UK.